nsh Weekly Update MultiBriefs
Subscribe
Contact Us
Media Kit

Browse Categories

Browse by Date

Study: Organ-rejection drugs may help prevent Alzheimer's disease

The calcineurin inhibitors that organ transplant patients take to prevent rejection may also work to prevent Alzheimer's disease. A new study examined the rate of Alzheimer's disease among 2,600 organ transplant patients. Results were...

source: By Chelsea Adams
Search past issues
Search products and services

Amniotic fluid, the protective liquid surrounding an unborn baby, is discarded as medical waste during caesarean section deliveries. However, there is increasing evidence that this fluid is a source of valuable biological material,...

source: Lund Universityvia Science Daily

A study by Craig J. Ceol, Ph.D., assistant professor of molecular medicine at the University of Massachusetts Medical School, has revealed a protein active during early embryo development called GDF6 plays a primary role in metastatic melanoma. Published in the Journal of...

source: The Medical News

We are less than a week away from the 2017 VIR webinar Series, brought to you by the NSH VIR Committee. This year's topics include: Antibody Production: Polyclonals, Monoclonals, and New Developments; Simple Tools for 3-Dimensional Image Processing; Multiplexing on Animal...

source: NSH

Not currently an NSH member? When you join NSH today, not only are you receiving membership for 2018, but you are also getting the rest of 2017, at no cost. That means almost additional months of access to key resources you could benefit from, such as all of the tools available...

source: NSH

Head and neck tumors that contain cells undergoing a partial epithelial-to-mesenchymal transition — which transforms them from neatly organized blocks into irregular structures that extrude into the surrounding environment — are more likely to invade and spread...

source: Massachusetts Eye and Ear Infirmary via Medical Xpress

Johns Hopkins Kimmel Cancer Center researchers and colleagues have identified a novel drug combination therapy that could prime nonsmall cell lung cancers to respond better to immunotherapy. These so-called epigenetic therapy drugs,...

source: Johns Hopkins University School of Medicine via Medical Xpress

RECOMMENDED:

Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to Under the Microscope

*Email:
*First Name:
*Last Name:
*Company:
Title:
Street Address:
City:
State / Province:
Zip / Postal Code:
Country:
Are you a member of NSH? Yes   No
Privacy Policy
X